An
experimental drug has shown promise in treating influenza, preventing lung
injury and death from the virus in preclinical studies, according to University
of Maryland School of Medicine researchers publishing in the journal Nature.
The
scientists found that a drug called Eritoran can protect mice from death after
they have been infected with a lethal dose of influenza virus.
The
findings are of particular interest to scientists now that the latest deadly
strain of flu, H7N9, is spreading in China.
For
further details refer to the following on-line open access journal:
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources